What was the highest achieced in MAPBI3 in psc in scaps 1d in ml?
Best insight from top research papers
The highest achieved power conversion efficiency (PCE) in MAPbI3-based perovskite solar cells (PSC) using SCAPS-1D simulation was 25.76% at a band-gap of 1.3 eV . Additionally, a high-performance MAPbI3 device with a PCE of 20.09% was achieved through structural and basic optimizations, including defect suppression, resulting in an enhanced V oc of 1.087 V, J sc of 22.56 mA cm−2, and FF of 78.5% . Furthermore, the optimization of an inorganic non-toxic PSC using CsGeI3 in SCAPS-1D led to a PCE of 17.61% with an optimized structure of C60/CsGeI3/CuSCN, showcasing an open-circuit voltage (Voc) of 1.0169 V and a short-circuit current density (Jsc) of 19.653 mA cm−2 .
Answers from top 5 papers
More filters
Papers (5) | Insight |
---|---|
06 May 2023 | Not addressed in the paper. |
25 Oct 2019 | The highest achieved efficiency in MAPbI3 in PSC using SCAPS-1D was greater than 20%, showcasing the potential of hybrid Perovskite solar cells. |
The highest achieved power conversion efficiency in MAPbI3 perovskite solar cells using SCAPS-1D was 20.09%, with an enhanced V oc of 1.087 V, J sc of 22.56 mA cm−2, and FF of 78.5%. | |
The highest achieved power conversion efficiency (PCE) in MAPbI3-based PSC using SCAPS-1D simulation was 25.76% at a band-gap of 1.3 eV. | |
2 Citations | Not addressed in the paper. |
Related Questions
What is rule of DMF in making MAPbI3?4 answersThe role of DMF (N, N-dimethylformamide) in the formation of MAPbI3 (methylammonium lead iodide) perovskite involves various processes. DMF breakdown triggers the formation of ethylammonium lead iodide (CH3CH2NH3PbI3/EAPbI3) during annealing, as observed in. Additionally, the use of DMF in precursor solutions leads to the formation of different intermediate compounds depending on the ratios of PbI2 and CH3NH3I, impacting the perovskite film morphology. Furthermore, the preferential precipitation of DMSO-adduct over DMF-adduct in antisolvent approaches, influenced by DMF, affects the crystallization pathways of perovskite films, as discussed in. Therefore, DMF plays a crucial role in the synthesis and morphology control of MAPbI3 perovskite films through its impact on intermediate phases, cation exchange reactions, and crystallization pathways.
What was the highest achieced in MAPBI3 in psc in scaps 1d?5 answersThe highest power conversion efficiency (PCE) achieved in MAPbI3-based perovskite solar cells (PSC) using SCAPS-1D simulation was 25.76% at a band-gap of 1.3 eV. Additionally, in a different study, a lead-free perovskite solar cell model with a structure of Glass/TCO/PCBM/CH3NH3PbI3/CuO/Au reached a PCE of 27.78% with a perovskite layer thickness of 0.45 μm. Furthermore, a HTM-free PSC structure with TiO2, CH3NH3PbI3, and Pt as ETM achieved a PCE of 25.75% after optimizing various parameters like thickness of ETM, absorber, doping concentrations, and electron affinity. These studies collectively demonstrate the significant advancements in enhancing the efficiency of MAPbI3-based PSCs through meticulous simulation and optimization techniques.
What is the role of PABC1L in melanoma development?5 answersPABC1L, also known as PARP1, plays a crucial role in melanoma development. Studies have shown that PARP1 is overexpressed in melanoma, correlating with advanced stages and poor prognosis. Additionally, the 1q42.1 melanoma risk allele is associated with higher PARP1 levels, promoting cell proliferation and potentially contributing to melanomagenesis. On the other hand, PS-1, a component of the γ-secretase complex, has been linked to melanoma aggressiveness through its impact on Wnt signaling, suggesting that enhancing PS-1 expression could reduce Wnt-dependent melanoma progression. Furthermore, lncRNA PVT1 acts as an oncogene in melanoma by binding to miR-26b, promoting proliferation and inhibiting apoptosis in melanoma cells. Overall, these findings highlight the multifaceted roles of PARP1, PS-1, and PVT1 in melanoma development.
How the diffusion lenght affected by JSC in MAPbI3 where the Ln is around 4.6 um?5 answersThe diffusion length in MAPbI3 perovskite is significantly influenced by the short-circuit current density (JSC) and can reach around 4.6 µm. Studies have shown that the carrier diffusion length in perovskite materials can be enhanced through various methods. For instance, solvent-annealing has been identified as an effective technique to increase both the grain size and carrier diffusion lengths in trihalide perovskite materials, such as MAPbI3. Additionally, the carrier diffusion length in mixed lead-halide perovskites was found to be higher compared to halide perovskite films, indicating a potential improvement in carrier mobility. Furthermore, the carrier diffusion coefficient in wet-cast MAPbI3 perovskite films can be enhanced by additives, leading to a significant increase in diffusion length.
Is MLH3 implicated in breast cancer?4 answersMLH3 is not likely to be a significant contributor to breast cancer risk, at least when heterozygous. A germline nonsense variant in MLH3, p.Ser1188Ter, was identified in four Finnish polyposis families, three of which also exhibited breast cancer. However, the prevalence of the MLH3 p.Ser1188Ter variant in breast cancer patient cohorts from Northern Ostrobothnia did not differ from the population frequency, arguing against its association with breast cancer risk.
How to efficiently transfect PANC-1?2 answersEfficient transfection of PANC-1 cells can be achieved using various strategies. One approach is to use mesoporous silica nanoparticles (MSNs) encapsulating therapeutic agents such as gemcitabine and ferulic acid, functionalized with anti-GPC1 antibodies to target the cancer cells. Another method involves bio-conjugating resveratrol with gold nanoparticles (GNPs) to enhance its delivery performance and anti-tumor efficacy. Peptide-based drug targeting using SKAAKN conjugates containing daunomycin has also shown significant antitumor activity in PANC-1 cells. Additionally, a redox-responsive polyetherimide-based nanovector has been developed for efficient gene delivery, demonstrating excellent in vitro gene silencing effects in PANC-1 cells. These approaches provide potential strategies for efficient transfection of PANC-1 cells, offering new possibilities for the treatment of pancreatic cancer.